Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure

被引：0
|
作者：
Lei Chen
Joel W. Hay
机构：
[1] University of Southern California,Department of Pharmaceutical Economics and Policy
来源：
Cardiovascular Drugs and Therapy | 2004年 / 18卷
关键词：
Sudden Death; Congestive Heart Failure Patient; Primary Implant; Standard Drug Therapy; Congestive Heart Failure Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Implanted cardioverter defibrillator (ICD) is expensive but highly effective in preventing sudden death. The value of primary prophylactic ICD in preventing sudden death for congestive heart failure patients (CHF) has not been established.
引用
收藏
页码：161 / 170
页数：9
相关论文
共 50 条
  • [1] Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure
    Chen, L
    Hay, JW
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (02) : 161 - 170
  • [2] Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of sudden death
    Rodenas Alesina, E. Eduardo
    Ribera, A.
    Gimenez, E.
    Oristrell, G.
    Osorio, D.
    Marsal, J. R.
    Garcia-Perez, L.
    Ballesteros, M.
    Belahnech, Y.
    Escalona, R.
    Rivas, N.
    Roca-Luque, I.
    Ferreira-Gonzalez, I.
    Espallargues, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 7 - 8
  • [3] Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
    Ribera, Aida
    Gimenez, Emmanuel
    Oristrell, Gerard
    Osorio, Dimelza
    Ramon Marsal, Josep
    Garcia-Perez, Lidia
    Ballesteros, Monica
    Rodenas, Eduard
    Belahnech, Yassin
    Escalona, Roxana
    Rivas, Nuria
    Roca-Luque, Ivo
    Ferreira-Gonzalez, Ignacio
    Espallargues, Mireia
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (01): : 12 - 21
  • [4] Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation
    Healy, Christopher A.
    Carrillo, Roger G.
    HEART RHYTHM, 2015, 12 (07) : 1565 - 1573
  • [5] SURVIVAL OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECIPIENT FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE
    Joncas, S. X.
    Ayala-Paredes, F. A.
    Carrier, N.
    Farand, P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S342 - S342
  • [6] COST-EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PATIENTS WITH RISK FACTORS FOR SUDDEN DEATH IN ARGENTINA
    Alcaraz, A.
    Gonzalez Zuelgaray, J.
    Augustovski, F.
    VALUE IN HEALTH, 2011, 14 (07) : A535 - A535
  • [7] The implantable cardioverter defibrillator in congestive heart failure patients in primary prevention: assessment of neuropsychological impact
    Garnero, S.
    Pomero, A.
    Vallauri, P.
    Leto, L.
    Testa, M.
    Feola, M.
    MINERVA CARDIOANGIOLOGICA, 2014, 62 (04): : 321 - 326
  • [8] Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death
    Owens, DK
    Sanders, GD
    Harris, RA
    McDonald, KM
    Heidenreich, PA
    Dembitzer, AD
    Hlatky, MA
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) : 1 - 12
  • [9] Cardioverter-defibrillator in the primary prevention of sudden death: For all or for a few?
    Zimerman, Leandro Ioschpe
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2008, 91 (02) : 70 - 71
  • [10] Prevention of sudden death in congestive heart failure patients
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (3): : 122 - 122
12345